Pacira BioSciences: Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues

Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years-- BRISBANE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences ...
PregaTips on MSN

Myths about shoulder dystocia that expectant mothers should stop believing

Shoulder dystocia sounds like a scary term, but it’s often surrounded by unnecessary myths and fear. Understanding what it truly means helps you stay calm and confident during childbirth. This blog ...
Santé log

Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today reported preliminary, ...